SQZ Biotechnologies Company (SQZB)
OTCMKTS
· Delayed Price · Currency is USD
0.0250
-0.0030 (-10.71%)
Dec 27, 2024, 4:00 PM EST
SQZB Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
---|---|---|---|---|---|---|
Period Ending | Sep '23 Sep 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
Cash & Equivalents | 10.19 | 63.71 | 143.51 | 170.36 | 39.26 | 59.57 |
Short-Term Investments | - | - | - | - | 59.03 | 47.34 |
Cash & Short-Term Investments | 10.19 | 63.71 | 143.51 | 170.36 | 98.28 | 106.91 |
Cash Growth | -87.90% | -55.61% | -15.76% | 73.33% | -8.07% | - |
Accounts Receivable | - | - | 3 | 1.89 | 1.88 | 1.17 |
Other Receivables | - | 0.38 | 0.1 | 0.55 | 0.21 | 0.08 |
Receivables | - | 0.38 | 3.1 | 2.44 | 2.08 | 1.25 |
Prepaid Expenses | 1.89 | 4.11 | 4.03 | 4.03 | 1.45 | 0.65 |
Total Current Assets | 12.09 | 68.2 | 150.64 | 176.83 | 101.82 | 108.81 |
Property, Plant & Equipment | 15.4 | 29.39 | 72.89 | 52.01 | 48.21 | 4.43 |
Other Long-Term Assets | 2.31 | 2.31 | 2.63 | 2.31 | 2.32 | 2.31 |
Total Assets | 29.79 | 99.9 | 226.15 | 231.14 | 152.35 | 115.55 |
Accounts Payable | 1.91 | 2.51 | 3.97 | 3.71 | 2.8 | 1.09 |
Accrued Expenses | 4.52 | 12.06 | 6.81 | 6.62 | 6.36 | 2.27 |
Current Portion of Leases | 2.4 | 6.56 | 9.94 | 8.21 | 9.44 | - |
Current Unearned Revenue | - | 0.72 | 12.51 | 25.92 | 18.98 | 16.5 |
Other Current Liabilities | - | - | - | 0.74 | 0.7 | 1.47 |
Total Current Liabilities | 8.83 | 21.84 | 33.22 | 45.19 | 38.28 | 21.33 |
Long-Term Leases | 19.08 | 20.91 | 59.76 | 38.89 | 32.89 | - |
Long-Term Unearned Revenue | - | - | 9.2 | 19.66 | 21.85 | 29.22 |
Other Long-Term Liabilities | - | - | - | 0.21 | 0.74 | 2.14 |
Total Liabilities | 27.91 | 42.75 | 102.18 | 103.94 | 93.76 | 52.69 |
Common Stock | 0.03 | 0.03 | 0.03 | 0.03 | 0 | 0 |
Additional Paid-In Capital | 334.92 | 332.09 | 319.46 | 253.94 | 2.7 | 0.51 |
Retained Earnings | -333.07 | -274.97 | -195.51 | -126.77 | -76.25 | -44.05 |
Comprehensive Income & Other | - | - | - | - | 0.03 | -0 |
Total Common Equity | 1.88 | 57.15 | 123.98 | 127.2 | -73.52 | -43.54 |
Shareholders' Equity | 1.88 | 57.15 | 123.98 | 127.2 | 58.59 | 62.86 |
Total Liabilities & Equity | 29.79 | 99.9 | 226.15 | 231.14 | 152.35 | 115.55 |
Total Debt | 21.47 | 27.47 | 69.69 | 47.1 | 42.33 | - |
Net Cash (Debt) | -11.28 | 36.24 | 73.82 | 123.26 | 55.95 | 106.91 |
Net Cash Growth | - | -50.91% | -40.11% | 120.30% | -47.67% | - |
Net Cash Per Share | -0.38 | 1.26 | 2.68 | 22.82 | 32.83 | 70.95 |
Filing Date Shares Outstanding | 29.49 | 29.49 | 28.15 | 27.87 | 1.67 | 1.61 |
Total Common Shares Outstanding | 29.49 | 29.49 | 28.13 | 24.79 | 1.65 | 1.61 |
Working Capital | 3.26 | 46.36 | 117.41 | 131.64 | 63.54 | 87.48 |
Book Value Per Share | 0.06 | 1.94 | 4.41 | 5.13 | -44.56 | -27.11 |
Tangible Book Value | 1.88 | 57.15 | 123.98 | 127.2 | -73.52 | -43.54 |
Tangible Book Value Per Share | 0.06 | 1.94 | 4.41 | 5.13 | -44.56 | -27.11 |
Machinery | 6.79 | 7.16 | 6.98 | 6.6 | 6.01 | 3.98 |
Construction In Progress | - | - | - | - | - | 0.02 |
Leasehold Improvements | 0.58 | 0.58 | 0.58 | 0.58 | 2.65 | 2.65 |
Source: S&P Capital IQ. Standard template. Financial Sources.